Since the Indian government intends to double farm incomes by 2022, the company I would like to track would be Nath Bio-Genes.
Nath Bio-Genes has been a story of misses. Each time a recovery was estimated, this seed company underperformed.
It appears that the freak incidents that translated into under-performance could well be past; Nath Bio-Genes sits at the cusp of unprecedented opportunities.
The macro context: Hybrid paddy seeds account for only five per cent of all the land under paddy in India, whereas the corresponding coverage is around 70 per cent in China — an index of the vast scope for
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper
